» Articles » PMID: 38576479

The Ethnomedicine, Phytochemistry, and Pharmacological Properties of the Genus Bersama: Current Review and Future Perspectives

Overview
Journal Front Pharmacol
Date 2024 Apr 5
PMID 38576479
Authors
Affiliations
Soon will be listed here.
Abstract

Bersama (Melianthaceae) has been used in traditional medicine for a wide range of ailments, including blood purifier, immune booster, psychotropic medication, and treatment for malaria, hepatitis, infertility, diabetes, impotency, meningitis, and stroke. This review gathers fragmented information from the literature on ethnomedicinal applications, phytochemistry, pharmacology, and toxicology of the Bersama genus. It also explores the therapeutic potential of the Bersama genus in ethnophytopharmacology, allowing for further investigation. All the available information published in the English language on Bersama genus was compiled from electronic databases such as Academic Journals, Ethnobotany, Google Scholar, PubMed, Science Direct, Web of Science, and library search using the following keywords: "Bersama genus," "traditional use," "phytochemistry," "pharmacological effects," and "toxicology". The ethnomedical applications of the Bersama genus have been recorded, and it has been used traditionally for more than 30 different types of ailments. Thus far, more than 50 compounds have been isolated from the genus. Cardiac glycosides and terpenoids are the main compounds isolated from the genus. Different plant parts of genus extracts demonstrated a wide range of pharmacological properties, including antioxidant, antimalarial, antidiabetic, antiviral, anti-inflammatory, and cytotoxic activity. Exemplary drug leads from the genus include mangiferin and quercetin-3--arabinopyranoside, both of which have antioxidant activities. genus has long been used to cure a wide range of ailments. genus extracts and phytochemicals have been found to have promising pharmacological activities. Further study on promising crude extracts and compounds is required to develop innovative therapeutic candidates.

References
1.
Moshi M, Innocent E, Magadula J, Otieno D, Weisheit A, Mbabazi P . Brine shrimp toxicity of some plants used as traditional medicines in Kagera Region, north western Tanzania. Tanzan J Health Res. 2010; 12(1):63-7. DOI: 10.4314/thrb.v12i1.56287. View

2.
Sinan K, Bene K, Zengin G, Diuzheva A, Jeko J, Cziaky Z . A comparative study of the HPLC-MS profiles and biological efficiency of different solvent leaf extracts of two African plants: and . Int J Environ Health Res. 2019; 31(3):285-297. DOI: 10.1080/09603123.2019.1652885. View

3.
Zekeya N, Mamiro B, Ndossi H, Chande Mallya R, Kilonzo M, Kisingo A . Screening and evaluation of cytotoxicity and antiviral effects of secondary metabolites from water extracts of Bersama abyssinica against SARS-CoV-2 Delta. BMC Complement Med Ther. 2022; 22(1):280. PMC: 9598020. DOI: 10.1186/s12906-022-03754-3. View

4.
Ayalew M, Bekele A, Mengistie M, Atnafie S . Evaluation of the antidiarrheal activity of 80% methanol extract and solvent fractions of the leaf of Bersama abyssinica fresen (Melianthaceae) in mice. BMC Complement Med Ther. 2022; 22(1):8. PMC: 8734363. DOI: 10.1186/s12906-021-03498-6. View

5.
Zirihi G, Mambu L, Guede-Guina F, Bodo B, Grellier P . In vitro antiplasmodial activity and cytotoxicity of 33 West African plants used for treatment of malaria. J Ethnopharmacol. 2005; 98(3):281-5. DOI: 10.1016/j.jep.2005.01.004. View